全球醫(yī)藥產(chǎn)業(yè)研究與發(fā)展的最新趨勢(shì)-全文預(yù)覽
【正文】 percentage of RD expenditure invested in CMC Proportion of RD expenditure spent on CMC activities in 2023 Proportion of RD Full Time Equivalents allocated to CMC in 2023 CMC outsourcing expenditure as a percentage of total CMC expenditure 34 ) Conclusions 結(jié)語(yǔ) ? 開(kāi)發(fā)具有國(guó)內(nèi)或國(guó)外水平的新藥不僅要依靠企業(yè)本身的實(shí)力 , 還要眼光向外 . 有效的引進(jìn)新項(xiàng)目及專(zhuān)利是目前國(guó)際上流行做法 . ? 對(duì)已有的上市產(chǎn)品， 要利用新技術(shù)進(jìn)行多次開(kāi)發(fā)和產(chǎn)品周期管理 (LCM)，以維持和延續(xù)產(chǎn)品的壽命和市場(chǎng)份額。 ? Drug Licensee Licensor Launched 2023 sales (mio USD) ? Paxil GSK Novo Nordisk 1991 2,055 ? Pravachol BMS Sankyo 1990 2,266 ? Fosamax Merck Gentili 1993 2,250 ? Lipitor Pfizer Warner Lamb 1997 7,972 ? Celexa Forest Labs Lundbeck 1998 1,451 12 ) Revenues from inlicensing are increasing… 引進(jìn)項(xiàng)目的產(chǎn)品銷(xiāo)售正在不斷提高 3 5 4 530*24*1992 1997 2023EShare of revenues from inlicensing Top 10 pharmacos * Classified products account for over 70 % of prescription revenues Source: Analyst reports。 annual reports。 ? 一旦中國(guó)的產(chǎn)品質(zhì)量，技術(shù)及 GMP得已保證， Outsourcing, Generic chemical drug and biotech strategy 中國(guó)的制藥企業(yè)對(duì)上述所提的問(wèn)題都得到加強(qiáng)時(shí)，那么中國(guó)制藥企業(yè)的崛起將為時(shí)不遠(yuǎn) … 35 ) Questions??? ??? 謝謝 ! 36 ) 謝謝觀(guān)看 /歡迎下載 BY FAITH I MEAN A VISION OF GOOD ONE CHERISHES AND THE ENTHUSIASM THAT PUSHES ONE TO SEEK ITS FULFILLMENT REGARDLESS OF OBSTACLES. BY FAITH I BY FAITH 。 literature search。) 全球醫(yī)藥產(chǎn)業(yè) 研究 與發(fā)展的最新趨勢(shì) 胡江濱 美中藥協(xié) (SAPA) 北京 , 2023 1 ) 報(bào)告內(nèi)容 ? 全球制藥界新藥開(kāi)發(fā)最新概況 ? 新藥開(kāi)發(fā)值得注意的走向 ? Project inlicensing 項(xiàng)目引進(jìn) ? Life Cycle Management (LCM) 產(chǎn)品周期的管理 ? Outsourcing What Why and (How) ? 2 ) 223 236 249 285 296 297 308 337 364 396 0 100 200 300 400 500 600 1992 1993 1994 1995 1996 1997 1998 1999 2023 2023 2023p 2023p Global pharmaceutical sales (US$ billion) 420 445 Year p = projection Source: Sales data for 19922023 supplied by IMS Health 全球藥品銷(xiāo)售 19922023p 3 ) 0 60 80 100 120 140 160 180 200 1992 1993 1994 1995 1996 1997 1998 1999 2023 2023 2023p Year Indexed values (1992 = 100) 全球研發(fā)費(fèi)用 全球新藥上市 研發(fā)時(shí)間 (3 year moving
教學(xué)課件相關(guān)推薦
鄂ICP備17016276號(hào)-1